272 related articles for article (PubMed ID: 25115739)
1. Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients.
Peters KB; West MJ; Hornsby WE; Waner E; Coan AD; McSherry F; Herndon JE; Friedman HS; Desjardins A; Jones LW
J Neurooncol; 2014 Dec; 120(3):499-506. PubMed ID: 25115739
[TBL] [Abstract][Full Text] [Related]
2. Exercise behavior, functional capacity, and survival in adults with malignant recurrent glioma.
Ruden E; Reardon DA; Coan AD; Herndon JE; Hornsby WE; West M; Fels DR; Desjardins A; Vredenburgh JJ; Waner E; Friedman AH; Friedman HS; Peters KB; Jones LW
J Clin Oncol; 2011 Jul; 29(21):2918-23. PubMed ID: 21690470
[TBL] [Abstract][Full Text] [Related]
3. Prospective study of quality of life in adults with newly diagnosed high-grade gliomas.
Brown PD; Ballman KV; Rummans TA; Maurer MJ; Sloan JA; Boeve BF; Gupta L; Tang-Wai DF; Arusell RM; Clark MM; Buckner JC
J Neurooncol; 2006 Feb; 76(3):283-91. PubMed ID: 16163448
[TBL] [Abstract][Full Text] [Related]
4. Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.
Arvold ND; Shi DD; Aizer AA; Norden AD; Reardon DA; Lee EQ; Nayak L; Dunn IF; Golby AJ; Johnson MD; Claus EB; Chiocca EA; Ligon KL; Wen PY; Alexander BM
J Neurooncol; 2017 Dec; 135(3):581-591. PubMed ID: 28975467
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival.
Brown PD; Maurer MJ; Rummans TA; Pollock BE; Ballman KV; Sloan JA; Boeve BF; Arusell RM; Clark MM; Buckner JC
Neurosurgery; 2005 Sep; 57(3):495-504; discussion 495-504. PubMed ID: 16145528
[TBL] [Abstract][Full Text] [Related]
6. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
7. Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas.
Wang C; Liu S; Peng L; Zhang K; Li W; Zhang H; Luan Y; Li P; Hu X
BMC Cancer; 2020 Jun; 20(1):591. PubMed ID: 32580723
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.
Cuneo KC; Vredenburgh JJ; Sampson JH; Reardon DA; Desjardins A; Peters KB; Friedman HS; Willett CG; Kirkpatrick JP
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2018-24. PubMed ID: 21489708
[TBL] [Abstract][Full Text] [Related]
9. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
[TBL] [Abstract][Full Text] [Related]
10. Analysis of factors influencing the access to concomitant chemo-radiotherapy in elderly patients with high grade gliomas: role of MMSE, age and tumor volume.
Di Cristofori A; Zarino B; Fanizzi C; Fornara GA; Bertani G; Rampini P; Carrabba G; Caroli M
J Neurooncol; 2017 Sep; 134(2):377-385. PubMed ID: 28685404
[TBL] [Abstract][Full Text] [Related]
11. Procarbazine, lomustine and vincristine for recurrent high-grade glioma.
Parasramka S; Talari G; Rosenfeld M; Guo J; Villano JL
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011773. PubMed ID: 28744879
[TBL] [Abstract][Full Text] [Related]
12. Therapy for Recurrent High-Grade Gliomas: Results of a Prospective Multicenter Study on Health-Related Quality of Life.
Stöckelmaier L; Renovanz M; König J; Nickel K; Hickmann AK; Mayer-Steinacker R; Nadji-Ohl M; Ganslandt O; Bullinger L; Wirtz CR; Coburger J
World Neurosurg; 2017 Jun; 102():383-399. PubMed ID: 28288921
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life of long-term high-grade glioma survivors.
Bosma I; Reijneveld JC; Douw L; Vos MJ; Postma TJ; Aaronson NK; Muller M; Vandertop WP; Slotman BJ; Taphoorn MJ; Heimans JJ; Klein M
Neuro Oncol; 2009 Feb; 11(1):51-8. PubMed ID: 18617599
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
Dahlrot RH
Dan Med J; 2014 Oct; 61(10):B4944. PubMed ID: 25283629
[TBL] [Abstract][Full Text] [Related]
15. Reirradiation with concurrent bevacizumab for recurrent high-grade gliomas in adult patients.
Schernberg A; Dhermain F; Ammari S; Dumont SN; Domont J; Patrikidou A; Pallud J; Dezamis É; Deutsch É; Louvel G
Cancer Radiother; 2018 Feb; 22(1):9-16. PubMed ID: 29217134
[TBL] [Abstract][Full Text] [Related]
16. Occurrence and predictors of the fatigue in high-grade glioma patients.
Aprile I; Chiesa S; Padua L; Di Blasi C; Arezzo MF; Valentini V; Di Stasio E; Balducci M
Neurol Sci; 2015 Aug; 36(8):1363-9. PubMed ID: 25698127
[TBL] [Abstract][Full Text] [Related]
17. Retrospective study of nivolumab for patients with recurrent high grade gliomas.
Mantica M; Pritchard A; Lieberman F; Drappatz J
J Neurooncol; 2018 Sep; 139(3):625-631. PubMed ID: 29779086
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in patients with high-grade gliomas: a quantitative longitudinal study.
Piil K; Jakobsen J; Christensen KB; Juhler M; Jarden M
J Neurooncol; 2015 Sep; 124(2):185-95. PubMed ID: 26026860
[TBL] [Abstract][Full Text] [Related]
19. Quality of life measures in glioma patients with different grades: A preliminary study.
Mahalakshmi P; Vanisree AJ
Indian J Cancer; 2015; 52(4):580-5. PubMed ID: 26960484
[TBL] [Abstract][Full Text] [Related]
20. A machine learning-based survival prediction model of high grade glioma by integration of clinical and dose-volume histogram parameters.
Chen H; Li C; Zheng L; Lu W; Li Y; Wei Q
Cancer Med; 2021 Apr; 10(8):2774-2786. PubMed ID: 33760360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
